Skip to main content

SABCS 2017 Highlights

Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor

Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor

FEATURING:

Hope S. Rugo, MD

Breast Cancer, SABCS 2017 Highlights, SABCS Highlights

HER2-Positive Breast Cancer and CDK4/6 Inhibitors

HER2-Positive Breast Cancer and CDK4/6 Inhibitors

FEATURING:

Hope S. Rugo, MD

Breast Cancer, SABCS 2017 Highlights, SABCS Highlights